Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1996
12/19/1996CA2224180A1 Ketoheterocyclic inhibitors of factor xa
12/19/1996CA2224170A1 Delivery of drugs to the lower gi tract
12/19/1996CA2224160A1 Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof
12/19/1996CA2224119A1 Method for treating multiple sclerosis
12/19/1996CA2224115A1 Multidentate metal complexes and methods of making and using thereof
12/19/1996CA2224113A1 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
12/19/1996CA2224103A1 Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions
12/19/1996CA2224102A1 Bacterial inhibition with an oligosaccharide compound
12/19/1996CA2224100A1 Novel benzopyran compounds and methods for their use
12/19/1996CA2224079A1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
12/19/1996CA2224064A1 Methods and system for processing dispersible fine powders
12/19/1996CA2224005A1 Optically pure (-) norcisapride for treating digestive tract disorders
12/19/1996CA2223996A1 Neuroactive steroids of the androstane and pregnane series
12/19/1996CA2223978A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders
12/19/1996CA2223967A1 Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers
12/19/1996CA2223962A1 2-substituted benzimidazole derivatives
12/19/1996CA2223948A1 Chalcone retinoids and methods of use of same
12/19/1996CA2223940A1 Macrophage activating factors derived from cloned vitamin d binding protein
12/19/1996CA2223939A1 2-substituted benzimidazole derivatives
12/19/1996CA2223935A1 Semicarbazones having cns activity and pharmaceutical preparations containing same
12/19/1996CA2223928A1 Cationic lipid:dna complexes for gene targeting
12/19/1996CA2223921A1 Stabilization of polynucleotide complexes
12/19/1996CA2223912A1 Methods of combatting infectious diseases using dicationic bis-benzimidazoles
12/19/1996CA2223885A1 Platelet-specific chimeric immunoglobulin and methods of use therefor
12/19/1996CA2223878A1 Inhibitors of phospholipase a2
12/19/1996CA2223828A1 New cryptophycins
12/19/1996CA2223803A1 Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers
12/19/1996CA2223747A1 Antifungal compositions
12/19/1996CA2223739A1 Dehydroepiandrosterone derivatives for preventing progressive tissue necrosis reperfusion injury, bacterial translocation and adult respiratory distress syndrome
12/19/1996CA2223727A1 Arylsulfonylaminobenzene derivatives and the use thereof as factor xa inhibitors
12/19/1996CA2223718A1 Retinoids and methods of use of same
12/19/1996CA2223717A1 Modified steroid hormones for gene therapy and methods for their use
12/19/1996CA2223711A1 Calcium channel antagonists
12/19/1996CA2223696A1 Novel derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
12/19/1996CA2223640A1 Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides
12/19/1996CA2223605A1 Stable formulations of mhc-peptide complexes
12/19/1996CA2223592A1 Triterpenes
12/19/1996CA2223590A1 Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors
12/19/1996CA2223584A1 Crosslinking oligonucleotides
12/19/1996CA2223581A1 Use of debromohymenialdisine and related compounds for treating osteoarthritis
12/19/1996CA2223557A1 Method of improving animal health
12/19/1996CA2223549A1 Capped synthetic rna, analogs, and aptamers
12/19/1996CA2223533A1 Imidazole compounds
12/19/1996CA2223499A1 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
12/19/1996CA2223462A1 Use of pseudopterosins for promoting wound healing
12/19/1996CA2223435A1 Use of benzimidazoles for the manufacture of a medicament for the treatment of leukemia
12/19/1996CA2223426A1 N-substituted piperazine nonoates
12/19/1996CA2223395A1 Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
12/19/1996CA2223391A1 Method for preparing n-monosubstituted and n,n'-disubstituted unsymmetrical cyclic ureas
12/19/1996CA2223385A1 Stabilized steroid compositions
12/19/1996CA2223327A1 Augmented atp production
12/19/1996CA2223324A1 Alpha hydroxyacid esters for skin aging
12/19/1996CA2223299A1 Anti-viral compounds
12/19/1996CA2223292A1 Single chain analogs of the tgf-.beta. superfamily (morphons)
12/19/1996CA2223275A1 High affinity nucleic acid ligands to lectins
12/19/1996CA2223268A1 .alpha.-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
12/19/1996CA2223179A1 Phosphonic acid-based cationic lipids
12/19/1996CA2223175A1 Methods of inducing bef-1 transcription factor
12/19/1996CA2223122A1 Conversion of compactin to pravastatin by actinomadura
12/19/1996CA2223109A1 Use of antisense oligonucleotides to il-6 receptor mrna to inhibit cellular proliferation
12/19/1996CA2223093A1 Anti-viral compounds
12/19/1996CA2223092A1 Methods of modulating nf-kb transcription factor
12/19/1996CA2223077A1 Thrombin receptor homolog
12/19/1996CA2223041A1 Immunological combination compositions and methods
12/19/1996CA2223003A1 High-affinity nucleic acid ligands of cytokines
12/19/1996CA2222999A1 Novel ctla4/cd28 ligands and uses therefor
12/19/1996CA2222972A1 Reversible cysteine protease inhibitors
12/19/1996CA2222947A1 Inhibin compositions and methods of enhancing production performance
12/19/1996CA2222930A1 Treatment of a trabecular meshwork whose cells are subject to inhibition of cell division with non-steroidal anti-inflammatory drugs
12/19/1996CA2222929A1 Non-steroidal anti-inflammatory drugs for the cyto-protection of the trabecular meshwork
12/19/1996CA2222793A1 Optimized minizymes and miniribozymes and uses thereof
12/19/1996CA2222776A1 Biological agent compositions
12/19/1996CA2222739A1 Modulation of calcium channels
12/19/1996CA2222652A1 1h-4(5)-substituted imidazole derivatives
12/19/1996CA2222625A1 Treatment and prevention of prostatic disease
12/19/1996CA2222593A1 Use of vitamin d4 derivatives for treating cancer
12/19/1996CA2222591A1 Use of vitamin d4 derivatives for treating skin disorders
12/19/1996CA2222586A1 Thiocationic lipids, pharmaceutical compositions and methods of use thereof
12/19/1996CA2222574A1 Oral delivery of adeno-associated viral vectors
12/19/1996CA2222545A1 Quinazolines and pharmaceutical compositions
12/19/1996CA2222520A1 Oligonucleotides specific for cytokine signal transducer gp130 mrna
12/19/1996CA2222492A1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
12/19/1996CA2222491A1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
12/19/1996CA2222472A1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
12/19/1996CA2222420A1 Novel 5-cyclopropyl-1,4 benzodiazepine-2-ones
12/19/1996CA2222335A1 Cytotoxic macrolides
12/19/1996CA2222330A1 Novel n-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1h-benzo¬b|¬1,4|diazepin-3-yl)-acetamides
12/19/1996CA2222316A1 Dihydrophthalazine antagonists of excitatory amino acid receptors
12/19/1996CA2222231A1 Antibody and antibody fragments for inhibiting the growth of tumors
12/19/1996CA2222224A1 Nucleotide analogues for topical treatment of proliferative disease of the skin
12/19/1996CA2222183A1 Stable reagents for the preparation of radiopharmaceuticals
12/19/1996CA2222154A1 Acyclovir derivatives for topical use
12/19/1996CA2222066A1 Hemodilution facilitated by monitoring oxygenation status
12/19/1996CA2221965A1 Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir
12/19/1996CA2221867A1 Small molecule inhibition of rna/ligand binding
12/19/1996CA2221746A1 Alpha 1a adrenergic receptor antagonists
12/19/1996CA2221744A1 Alpha 1a adrenergic receptor antagonists
12/19/1996CA2221690A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
12/19/1996CA2221602A1 Essential oligonucleotides of vertebrate telomerase
12/19/1996CA2221480A1 Mutants of streptococcal toxin a and methods of use
1 ... 6847 6848 6849 6850 6851 6852 6853 6854 6855 6856 6857 6858 6859 6860 6861 6862 6863 6864 6865 6866 6867 ... 7860